Author： Dragalin Vladimir
Publisher： Taylor & Francis Ltd
ISSN： 1054-3406
Source： Journal of Biopharmaceutical Statistics, Vol.17, Iss.6, 2007-11, pp. : 1051-1070
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
We propose an adaptive procedure for dose-finding in clinical trials when the primary efficacy endpoint is continuous. We model the mean of the efficacy endpoint, given the dose, as a four-parameter logistic function. The efficacy endpoint at each dose is distributed according to either a normal or a gamma distribution. We consider the cases of fixed variance and fixed coefficient of variation assuming them to be both known and unknown. The analytic formulae for the Fisher information matrix are obtained, which are used to build the locally and adaptive D-optimal designs.
Related content
Access to resources
Recommend
